Anxious legislators have proposed a five-bill package, the "Consumer Prescription Protection Act, " that's designed to even the score, as well as to regulate PBMs and force more accounting transparency (detailing, for example, the rebates they receive from pharmas).
Should the federal government, acting on be-half not only of stockholders and creditors but of the general public as well, force its own accounting standards on business?